Skip to main content

. 1959 Jun 20;1(5137):1541–1549. doi: 10.1136/bmj.1.5137.1541

Large-scale Use of Sabin Type 2 Attenuated Poliovirus Vaccine in Singapore During a Type 1 Poliomyelitis Epidemic

J H Hale, M Doraisingham, K Kanagaratnam, K W Leong, E S Monteiro

PMCID: PMC1993778 PMID: 13662613

1543

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

CLARKE S. K., GOFFE A. P., STUART-HARRIS C. H., HERZOG E. G. A small-scale trial of type III attenuated living poliovirus vaccine. Br Med J. 1958 Nov 15;2(5106):1188–1193. doi: 10.1136/bmj.2.5106.1188. [DOI] [PMC free article] [PubMed] [Google Scholar]
CONNOLLY J. H., DANE D. S., DICK G. W., FISHER O. D., MCKEOWN F. Vaccination against poliomyelitis with live virus vaccines. II. A trial of SM type I attenuated poliomyelitis virus vaccine. Br Med J. 1957 Jan 12;1(5010):65–70. [PMC free article] [PubMed] [Google Scholar]
DANE D. S., DICK G. W. Vaccination against poliomyelitis with live virus vaccines. III. The evaluation to TN and SM virus vaccines. Br Med J. 1957 Jan 12;1(5010):70–74. [PubMed] [Google Scholar]
KOPROWSKI H. Living attenuated poliomyelitis virus as an immunizing agent of man. S Afr Med J. 1955 Oct 29;29(49):1134–1142. [PubMed] [Google Scholar]
SABIN A. B. Present status of attenuated live-virus poliomyelitis vaccine. J Am Med Assoc. 1956 Dec 29;162(18):1589–1596. doi: 10.1001/jama.1956.02970350005002. [DOI] [PubMed] [Google Scholar]
SABIN A. B. Properties and behavior of orally administered attenuated poliovirus vaccine. J Am Med Assoc. 1957 Jul 13;164(11):1216–1223. doi: 10.1001/jama.1957.62980110008008. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES